Review of pneumococcal conjugate vaccine in adults: implications on clinical development

Area of Science:

• Immunology
• Vaccinology
• Public Health

Background:

• Pneumococcal conjugate vaccines (PCVs) are highly effective in children.
• The immunogenicity and efficacy of PCVs in adults, including immunocompromised individuals, require further investigation.
• Comparison with existing polysaccharide vaccines (PPSVs) is crucial for adult vaccination strategies.

Purpose of the Study:

• To review the literature on pneumococcal conjugate vaccine immunogenicity in adults.
• To compare PCV efficacy in adults with that observed in children.
• To assess PCV superiority over polysaccharide vaccines in adult populations.

Main Methods:

• A literature review was performed.
• Fifteen relevant publications were retrieved and analyzed.
• Studies included diverse populations, manufacturers, and methodologies.

Main Results:

• No clear evidence emerged demonstrating the superiority of PCVs over PPSVs in adults.
• Immunogenicity data varied across studies, influenced by vaccine type, population, and methodology.
• The efficacy in adults did not consistently match the high efficacy seen in children.

Conclusions:

• Current evidence does not support the superiority of PCVs over PPSVs for adult immunization.
• Factors influencing PCV immunogenicity in adults warrant further investigation.
• Implications for future vaccine development and adult vaccination policies are discussed.